Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Pharmaceutical Executive Europe E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, which is your preferred social media tool for professional use?

Twitter 14%
LinkedIn 74%
Facebook 0%
Other 12%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com

22 February, 2012
In this Issue
The Italian's Job: Guido Rasi's EMA Challenge
Some sly smiles flickered across the lips of European pharma veterans last year, when it started to look like an Italian was going to be put in charge of the European Medicines Agency. Those with long memories recalled how the last Italian in such a distinguished role wound up in prison... More...
How the European Crisis is Affecting Outsourcing to Emerging Markets
With Europe's economic troubles causing domestic profitability concerns, established pharmaceutical companies may look to emerging markets for outsourcing partners... More...
Sales: Are You Fully Mobilizing Your Mobile Technology?
So far companies have only scratched the surface of the potential — for example, location-based services and real-time collaboration — offered by the 'new mobile ecosystem', writes Neeraj Singhal. More...
Pharm Exec's Sales Force Survey: Too Much Business as Usual?
A snapshot of the current 'state of the art' of sales force effectiveness, drawn from the Hay Group's Annual Study... More...
Also in this issue…
FDA and Roche Warn of Counterfeit Avastin
2012: A Good, Bad or Ugly year for Servier?
Pharm Exec 2012 Ad Stars: A Call for Submissions
Event Profile
Pharma Regulatory Policy Exchange
May 7-8, 2012
Washington, D.C.
USA
Prepare for a new wave of legislative and regulatory policies that will shape the life sciences industry for years to come. Learn best practices on how the shifting regulatory and policy landscape will affect the biopharma industry going forward with Bayer HealthCare Pharmaceuticals, Bristol Myers Squibb, Eisai, Eli Lilly and Company, EMD Serono, Merck, Novartis and Shire Pharmaceuticals!
Register by March 10th at http://www.cbinet.com/policyexchange and save $300 with priority code: QSS925.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK